MESSAGES FROM THE MANAGEMENT:
WHY MRFR?
MRFR OFFERINGS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
1.1 MARKET ATTRACTIVENESS ANALYSIS 15
1.1.1 GLOBAL Breast BIOPSY MARKET, BY Product Type 15
1.1.2 GLOBAL Breast BIOPSY MARKET, BY Technique 16
1.1.3 GLOBAL Breast Biopsy MARKET, BY Guidance Technique 17
1.1.4 GLOBAL Breast Biopsy MARKET, BY End User 18
1.1.5 GLOBAL Breast Biopsy MARKET, BY REGION 19
2 MARKET INTRODUCTION 20
2.1 DEFINITION 20
2.2 SCOPE OF THE STUDY 20
2.3 RESEARCH OBJECTIVE 20
2.4 MARKET STRUCTURE 21
3 RESEARCH METHODOLOGY 22
3.1 DATA MINING 22
3.2 SECONDARY RESEARCH 23
3.3 PRIMARY RESEARCH 23
3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24
3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS 25
3.4 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 27
3.4.1 BOTTOM-UP APPROACH 27
3.4.2 TOP-DOWN APPROACH 28
3.5 DATA VALIDATION 28
3.6 ASSUMPTIONS & LIMITATIONS 29
4 MARKET DYNAMICS 30
4.1 INTRODUCTION 30
4.2 DRIVERS 31
4.2.1 Increase in the prevalence of breast cancer 31
4.2.2 Rising healthcare expenditure 31
4.3 RESTRAINT 32
4.3.1 Stringent regulation 32
4.3.2 High cost of breast biopsy 32
4.4 OPPORTUNITIES 33
4.4.1 A rise in early-stage breast cancer detection programmes 33
4.4.2 Growing initiatives by government 33
4.5 CHALLENGES 33
4.5.1 Risk of infection 33
4.5.2 Underdeveloped healthcare infrastructure 33
4.6 PRICING 34
5 MARKET FACTOR ANALYSIS 35
5.1 VALUE CHAIN ANALYSIS/SUPPLY CHAIN ANALYSIS 35
5.1.1 R&D 35
5.1.2 Manufacturing 36
5.1.3 Distribution & Sales 36
5.1.4 Post-Sales Monitoring 36
5.2 PORTER’S FIVE FORCES MODEL 37
5.2.1 Threat of New Entrants 37
5.2.2 BARGAINING POWER OF SUPPLIERS 38
5.2.3 Threat of Substitutes 38
5.2.4 Bargaining Power of Buyers 38
5.2.5 Intensity of Rivalry 38
5.3 IMPACT OF CORONAVIRUS OUTBREAK ON GLOBAL MARKET 39
5.3.1 Overview 39
5.3.2 IMPACT ON THE GLOBAL Breast Biopsy MARKET 39
5.3.3 IMPACT ON SUPPLY CHAIN OF Breast Biopsy market 39
5.3.4 IMPACT ON Pricing Breast Biopsy MARKET 40
5.3.5 IMPACT ON Key Players 40
6 GLOBAL BREAST BIOPSY MARKET, BY PRODUCT TYPE 41
6.1 INTRODUCTION 41
6.2 BIOPSY NEEDLES 42
6.3 BIOPSY TABLES 42
6.4 BIOPSY WIRES 42
6.5 GUIDANCE SYSTEMS 43
7 GLOBAL BREAST BIOPSY MARKET, BY TECHNIQUE TYPE 44
7.1 INTRODUCTION 44
7.2 FINE NEEDLE ASIPIRATION BIOPSY 45
7.3 CORE NEEDLE BIOPSY 45
7.3.1 Stereotactic Core Needle Biopsy 46
7.3.2 Vacuum-Assiated Biopsies 46
7.3.3 Ultrasound-Guided Core Biopsy 46
7.3.4 Freehand Needle Biopsy 46
7.4 BIOPSY MARKERS 47
7.5 MRI-GUIDED CORE NEEDLE BIOPSY 47
7.6 SURGICAL BIOPSY 47
7.7 SURGICAL BIOPSY 47
7.7.1 Incisional Biopsy 47
7.7.2 Excisional Biopsy 48
7.8 WIRE LOCALIZATION 48
7.9 SENTINEL NODE BIOPSY 48
8 GLOBAL BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE 49
8.1 INTRODUCTION 49
8.2 ULTRASOUND-GUIDED BIOPSY 50
8.3 MAMMOGRAPHY GUIDED MAGNETIC RESONANCE 50
8.4 CT GUIDED BIOPSY 50
8.5 OTHER IMAGE-GUIDED BREAST BIOPSY (PET AND THERMOGRAPHY) 50
9 GLOBAL BREAST BIOPSY MARKET, BY END USER 51
9.1 INTRODUCTION 51
9.2 HOSPITALS AND CLINICS 52
9.3 DIAGNOSTICS AND IMAGING CENTERS 52
9.4 ACADEMIC AND RESEARCH INSTITUTES 52
10 GLOBAL BREAST BIOPSY MARKET, BY REGION 53
10.1 INTRODUCTION 53
10.2 NORTH AMERICA 54
10.2.1 US 57
10.2.2 Canada 60
10.3 EUROPE 63
10.3.1 Germany 66
10.3.2 France 69
10.3.3 UK 71
10.3.4 Italy 74
10.3.5 Spain 76
10.3.6 Rest of Europe 79
10.4 ASIA PACIFIC 82
10.4.1 China 85
10.4.2 India 88
10.4.3 Japan 90
10.4.4 Australia 93
10.4.5 south korea 95
10.4.6 Rest of Asia Pacific 98
10.5 ROW 101
10.5.1 MIDDLE EAST and africa 104
10.5.2 Africa 107
10.5.3 latin america 109
11 COMPETITIVE LANDSCAPE 112
11.1 COMPETITIVE OVERVIEW 112
11.2 COMPETITOR DASHBOARD 113
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL BREAST BIOPSY MARKET 114
11.4 COMPETITIVE BENCHMARKING 115
11.5 MARKET SHARE ANALYSIS 116
11.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL BREAST BIOPSY MARKET 116
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 117
11.7.1 NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT 117
11.7.2 MERGER & ACQUISITION 118
11.7.3 JOINT VENTURES 118
11.7.4 Expansion 118
11.8 MAJOR PLAYERS FINANCIAL MATRIX 119
11.8.1 Sales 119
11.8.2 R&D Expenditure 119
12 COMPANY PROFILES 120
12.1 LEICA BIOSYSTEMS 120
12.1.1 COMPANY OVERVIEW 120
12.1.2 PRODUCTS OFFERed 120
12.1.3 KEY DEVELOPMENTS 120
12.1.4 SWOT Analysis 121
12.1.5 KEY STRATEGY 121
12.2 C.R. BARD INC. 122
12.2.1 COMPANY OVERVIEW 122
12.2.2 PRODUCTS OFFERed 122
12.2.3 SWOT Analysis 123
12.2.4 KEY STRATEGY 123
12.3 NUVUE THERAPEUTICS 124
12.3.1 COMPANY OVERVIEW 124
12.3.2 PRODUCTS OFFERed 124
12.3.3 SWOT Analysis 125
12.3.4 KEY STRATEGY 125
12.4 ARGON MEDICAL DEVICES, INC. 126
12.4.1 COMPANY OVERVIEW 126
12.4.2 PRODUCTS OFFERed 126
12.4.3 KEY DEVELOPMENTS 126
12.4.4 SWOT Analysis 127
12.4.5 KEY STRATEGY 127
12.5 BECTON, DICKINSON AND COMPANY 128
12.5.1 COMPANY OVERVIEW 128
12.5.2 FINANCIAL OVERVIEW 128
12.5.3 PRODUCTS OFFERed 129
12.5.4 KEY DEVELOPMENTS 129
12.5.5 SWOT Analysis 130
12.5.6 KEY STRATEGY 130
12.6 DEVICOR MEDICAL PRODUCTS INC. 131
12.6.1 COMPANY OVERVIEW 131
12.6.2 PRODUCTS OFFERed 131
12.6.3 KEY DEVELOPMENTS 131
12.6.4 SWOT Analysis 132
12.6.5 KEY STRATEGY 132
12.7 HOLOGIC INC. 133
12.7.1 COMPANY OVERVIEW 133
12.7.2 FINANCIAL OVERVIEW 133
12.7.3 PRODUCTS OFFERed 134
12.7.4 KEY DEVELOPMENTS 134
12.7.5 SWOT Analysis 135
12.7.6 KEY STRATEGY 135
12.8 MEDTRONIC PLC 136
12.8.1 COMPANY OVERVIEW 136
12.8.2 FINANCIAL OVERVIEW 136
12.8.3 PRODUCTS OFFERed 137
12.8.4 KEY DEVELOPMENTS 137
12.8.5 SWOT Analysis 138
12.8.6 KEY STRATEGY 138
12.9 COOK MEDICAL INCORPORATED 139
12.9.1 COMPANY OVERVIEW 139
12.9.2 PRODUCTS OFFERed 139
12.9.3 SWOT Analysis 140
12.9.4 KEY STRATEGY 140
12.10 PLANMED OY 141
12.10.1 COMPANY OVERVIEW 141
12.10.2 PRODUCTS OFFERed 141
12.10.3 KEY DEVELOPMENTS 141
12.10.4 SWOT Analysis 142
12.10.5 KEY STRATEGY 142
13 APPENDIX 143
13.1 REFERENCES 143
13.2 RELATED REPORTS 143
LIST OF TABLES
TABLE 1 MARKET SYNOPSIS 14
TABLE 2 LIST OF ASSUMPTIONS 29
TABLE 3 GLOBAL BREAST BIOPSY MARKET, PRICING (USD) 34
TABLE 4 GLOBAL BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 42
TABLE 5 GLOBAL BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 45
TABLE 6 GLOBAL BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 46
TABLE 7 GLOBAL BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 47
TABLE 8 GLOBAL BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 50
TABLE 9 GLOBAL BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 52
TABLE 10 GLOBAL BREAST BIOPSY MARKET, BY REGION, 2018-2030 (USD MILLION) 53
TABLE 11 NORTH AMERICA: BREAST BIOPSY MARKET, BY COUNTRY, 2018 TO 2030 (USD MILLION) 54
TABLE 12 NORTH AMERICA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 55
TABLE 13 NORTH AMERICA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 55
TABLE 14 NORTH AMERICA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 56
TABLE 15 NORTH AMERICA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 56
TABLE 16 NORTH AMERICA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 56
TABLE 17 NORTH AMERICA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 57
TABLE 18 US BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 57
TABLE 19 US BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 58
TABLE 20 US BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 58
TABLE 21 US BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 59
TABLE 22 US BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 59
TABLE 23 US BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 59
TABLE 24 CANADA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 60
TABLE 25 CANADA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 61
TABLE 26 CANADA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 61
TABLE 27 CANADA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 62
TABLE 28 CANADA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 62
TABLE 29 CANADA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 62
TABLE 30 EUROPE: BREAST BIOPSY MARKET, BY COUNTRY, 2018 TO 2030 (USD MILLION) 63
TABLE 31 EUROPE BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 64
TABLE 32 EUROPE BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 64
TABLE 33 EUROPE BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 65
TABLE 34 EUROPE BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 65
TABLE 35 EUROPE BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 65
TABLE 36 EUROPE BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 66
TABLE 37 GERMANY BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 66
TABLE 38 GERMANY BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 67
TABLE 39 GERMANY BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 67
TABLE 40 GERMANY BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 68
TABLE 41 GERMANY BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 68
TABLE 42 GERMANY BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 68
TABLE 43 FRANCE BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 69
TABLE 44 FRANCE BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 69
TABLE 45 FRANCE BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 70
TABLE 46 FRANCE BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 70
TABLE 47 FRANCE BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 70
TABLE 48 FRANCE BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 71
TABLE 49 UK BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 71
TABLE 50 UK BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 72
TABLE 51 UK BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 72
TABLE 52 UK BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 73
TABLE 53 UK BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 73
TABLE 54 UK BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 73
TABLE 55 ITALY BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 74
TABLE 56 ITALY BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 74
TABLE 57 ITALY BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 75
TABLE 58 ITALY BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 75
TABLE 59 ITALY BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 75
TABLE 60 ITALY BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 76
TABLE 61 SPAIN BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 76
TABLE 62 SPAIN BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 77
TABLE 63 SPAIN BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 77
TABLE 64 SPAIN BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 78
TABLE 65 SPAIN BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 78
TABLE 66 SPAIN BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 78
TABLE 67 REST OF EUROPE BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 79
TABLE 68 REST OF EUROPE BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 79
TABLE 69 REST OF EUROPE BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 80
TABLE 70 REST OF EUROPE BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 80
TABLE 71 REST OF EUROPE BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 80
TABLE 72 REST OF EUROPE BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 81
TABLE 73 ASIA PACIFIC: BREAST BIOPSY MARKET, BY COUNTRY, 2018 TO 2030 (USD MILLION) 82
TABLE 74 ASIA PACIFIC BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 83
TABLE 75 ASIA PACIFIC BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 83
TABLE 76 ASIA PACIFIC BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 84
TABLE 77 ASIA PACIFIC BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 84
TABLE 78 ASIA PACIFIC BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 84
TABLE 79 ASIA PACIFIC BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 85
TABLE 80 CHINA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 85
TABLE 81 CHINA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 86
TABLE 82 CHINA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 86
TABLE 83 CHINA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 87
TABLE 84 CHINA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 87
TABLE 85 CHINA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 87
TABLE 86 INDIA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 88
TABLE 87 INDIA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 88
TABLE 88 INDIA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 89
TABLE 89 INDIA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 89
TABLE 90 INDIA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 89
TABLE 91 INDIA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 90
TABLE 92 JAPAN BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 90
TABLE 93 JAPAN BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 91
TABLE 94 JAPAN BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 91
TABLE 95 JAPAN BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 92
TABLE 96 JAPAN BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 92
TABLE 97 JAPAN BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 92
TABLE 98 AUSTRALIA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 93
TABLE 99 AUSTRALIA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 93
TABLE 100 AUSTRALIA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 94
TABLE 101 AUSTRALIA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 94
TABLE 102 AUSTRALIA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 94
TABLE 103 AUSTRALIA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 95
TABLE 104 SOUTH KOREA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 95
TABLE 105 SOUTH KOREA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 96
TABLE 106 SOUTH KOREA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 96
TABLE 107 SOUTH KOREA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 97
TABLE 108 SOUTH KOREA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 97
TABLE 109 SOUTH KOREA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 97
TABLE 110 REST OF ASIA PACIFIC BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 98
TABLE 111 ASIA PACIFIC BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 98
TABLE 112 REST OF ASIA PACIFIC BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 99
TABLE 113 REST OF ASIA PACIFIC BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 99
TABLE 114 REST OF ASIA PACIFIC BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 99
TABLE 115 REST OF ASIA PACIFIC BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 100
TABLE 116 ROW: BREAST BIOPSY MARKET, BY COUNTRY, 2018 TO 2030 (USD MILLION) 101
TABLE 117 ROW BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 102
TABLE 118 ROW BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 102
TABLE 119 ROW BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 103
TABLE 120 ROW BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 103
TABLE 121 ROW BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 103
TABLE 122 ROW BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 104
TABLE 123 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 104
TABLE 124 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 105
TABLE 125 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 105
TABLE 126 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 106
TABLE 127 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 106
TABLE 128 MIDDLE EAST AND AFRICA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 106
TABLE 129 AFRICA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 107
TABLE 130 AFRICA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 107
TABLE 131 AFRICA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 108
TABLE 132 AFRICA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 108
TABLE 133 AFRICA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 108
TABLE 134 AFRICA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 109
TABLE 135 LATIN AMERICA BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION) 109
TABLE 136 LATIN AMERICA BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION) 110
TABLE 137 LATIN AMERICA BREAST BIOPSY MARKET, BY CORE NEEDLE BIOPSY, 2018-2030 (USD MILLION) 110
TABLE 138 LATIN AMERICA BREAST BIOPSY MARKET, BY SURGICAL BIOPSY, 2018-2030 (USD MILLION) 111
TABLE 139 LATIN AMERICA BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2018-2030 (USD MILLION) 111
TABLE 140 LATIN AMERICA BREAST BIOPSY MARKET, BY END USER, 2018-2030 (USD MILLION) 111
TABLE 141 COMPETITOR DASHBOARD: GLOBAL BREAST BIOPSY MARKET 113
TABLE 142 THE MOST ACTIVE PLAYER IN THE GLOBAL BREAST BIOPSY MARKET 116
TABLE 143 NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT 117
TABLE 144 MERGER & ACQUISITION 118
TABLE 145 JOINT VENTURES 118
TABLE 146 EXPANSION 118
TABLE 147 LEICA BIOSYSTEMS: PRODUCTS OFFERED 120
TABLE 148 LEICA BIOSYSTEMS: KEY DEVELOPMENTS 120
TABLE 149 C.R. BARD INC.: PRODUCTS OFFERED 122
TABLE 150 NUVUE THERAPEUTICS: PRODUCTS OFFERED 124
TABLE 151 ARGON MEDICAL DEVICES, INC.: PRODUCTS OFFERED 126
TABLE 152 ARGON MEDICAL DEVICES, INC.: KEY DEVELOPMENTS 126
TABLE 153 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 129
TABLE 154 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 129
TABLE 155 DEVICOR MEDICAL PRODUCTS INC.: PRODUCTS OFFERED 131
TABLE 156 DEVICOR MEDICAL PRODUCTS INC.: KEY DEVELOPMENTS 131
TABLE 157 HOLOGIC INC.: PRODUCTS OFFERED 134
TABLE 158 HOLOGIC INC.: KEY DEVELOPMENTS 134
TABLE 159 MEDTRONIC PLC: PRODUCTS OFFERED 137
TABLE 160 MEDTRONIC PLC: KEY DEVELOPMENTS 137
TABLE 161 COOK MEDICAL INCORPORATED: PRODUCTS OFFERED 139
TABLE 162 PLANMED OY: PRODUCTS OFFERED 141
TABLE 163 PLANMED OY: KEY DEVELOPMENTS 141
LIST OF FIGURES
FIGURE 1 GLOBAL BREAST BIOPSY MARKET ANALYSIS BY PRODUCT TYPE 15
FIGURE 2 GLOBAL BREAST BIOPSY MARKET ANALYSIS BY TECHNIQUE 16
FIGURE 3 GLOBAL BREAST BIOPSY MARKET ANALYSIS BY GUIDANCE TECHNIQUE 17
FIGURE 4 GLOBAL BREAST BIOPSY MARKET ANALYSIS BY END USER 18
FIGURE 5 GLOBAL BREAST BIOPSY MARKET ANALYSIS BY REGION 19
FIGURE 1 GLOBAL BREAST BIOPSY MARKET: STRUCTURE 21
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 27
FIGURE 3 MARKET DYNAMIC ANALYSIS OF THE GLOBAL BREAST BIOPSY MARKET 30
FIGURE 4 DRIVER IMPACT ANALYSIS 31
FIGURE 5 RESTRAINT IMPACT ANALYSIS 32
FIGURE 6 SUPPLY CHAIN: GLOBAL BREAST BIOPSY MARKET 35
FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL BREAST BIOPSY MARKET 37
FIGURE 8 GLOBAL BREAST BIOPSY MARKET, BY PRODUCT TYPE, 2020 TO 2030 (USD MILLION) 41
FIGURE 9 GLOBAL BREAST BIOPSY MARKET, BY TECHNIQUE TYPE, 2020 TO 2030 (USD MILLION) 44
FIGURE 10 GLOBAL BREAST BIOPSY MARKET, BY GUIDANCE TECHNIQUE, 2020 TO 2030 (USD MILLION) 49
FIGURE 11 GLOBAL BREAST BIOPSY MARKET, BY END USER, 2020 TO 2030 (USD MILLION) 51
FIGURE 12 GLOBAL BREAST BIOPSY MARKET, BY REGION, 2020 TO 2030 (USD MILLION) 53
FIGURE 13 NORTH AMERICA: BREAST BIOPSY MARKET SHARE (%), BY COUNTRY, 2021 54
FIGURE 14 EUROPE: BREAST BIOPSY MARKET SHARE (%), BY COUNTRY, 2021 63
FIGURE 15 ASIA PACIFIC: BREAST BIOPSY MARKET SHARE (%), BY COUNTRY, 2021 82
FIGURE 16 ROW: BREAST BIOPSY MARKET SHARE (%), BY COUNTRY, 2021 101
FIGURE 17 CONTRACTS & AGREEMENTS: THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL BREAST BIOPSY MARKET 114
FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS 115
FIGURE 19 MAJOR MANUFACTURER MARKET SHARE ANALYSIS, 2022 116
FIGURE 20 MAJ0R PLAYERS SALES, 2021 119
FIGURE 21 MAJ0R PLAYERS R&D EXPENDITURE, 2021 119
FIGURE 22 LEICA BIOSYSTEMS: SWOT ANALYSIS 121
FIGURE 23 C.R. BARD INC.: SWOT ANALYSIS 123
FIGURE 24 NUVUE THERAPEUTICS: SWOT ANALYSIS 125
FIGURE 25 ARGON MEDICAL DEVICES, INC.: SWOT ANALYSIS 127
FIGURE 26 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 128
FIGURE 27 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 130
FIGURE 28 DEVICOR MEDICAL PRODUCTS INC.: SWOT ANALYSIS 132
FIGURE 29 HOLOGIC INC.: FINANCIAL OVERVIEW SNAPSHOT 133
FIGURE 30 HOLOGIC INC.: SWOT ANALYSIS 135
FIGURE 31 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 136
FIGURE 32 MEDTRONIC PLC: SWOT ANALYSIS 138
FIGURE 33 COOK MEDICAL INCORPORATED: SWOT ANALYSIS 140
FIGURE 34 PLANMED OY: SWOT ANALYSIS 142
